about
Ziziphora tenuior L. essential oil from Dana Biosphere Reserve (Southern Jordan); Chemical characterization and assessment of biological activities.Chemical composition and biological activities of Artemisia judaica essential oil from southern desert of Jordan.Artemisia herba-alba essential oil from Buseirah (South Jordan): Chemical characterization and assessment of safe antifungal and anti-inflammatory doses.Myrtus communis L. as source of a bioactive and safe essential oil.Essential oil of common sage (Salvia officinalis L.) from Jordan: assessment of safety in mammalian cells and its antifungal and anti-inflammatory potentialComposition and anti-fungal activity of the essential oil from Cameroonian Vitex rivularis Gürke.Assessment of safe bioactive doses of Foeniculum vulgare Mill. essential oil from Portugal.Release kinetics and cell viability of ibuprofen nanocrystals produced by melt-emulsification.Anticancer Properties of Essential Oils and Other Natural Products.Ridolfia segetum (L.) Moris (Apiaceae) from Portugal: A source of safe antioxidant and anti-inflammatory essential oilChemical Composition and Antifungal Activity of Essential Oils and Supercritical CO2 Extracts of Apium nodiflorum (L.) LagIbuprofen nanocrystals developed by 22 factorial design experiment: A new approach for poorly water-soluble drugs.Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery EfficiencySonication-assisted Layer-by-Layer self-assembly nanoparticles for resveratrol deliveryNatural Products as a Source for New Leads in Cancer Research and TreatmentAcrocomia aculeata (Jacq.) Lodd. ex Mart. Leaves Increase SIRT1 Levels and Improve Stress ResistanceNanostructuring lipid carriers using Ridolfia segetum (L.) Moris essential oilHybrid Nanostructured Films for Topical Administration of Simvastatin as Coadjuvant Treatment of Melanoma
P50
Q38732911-5F189EFD-C317-4661-811C-64384AD13787Q38858590-72FF453F-D023-4A4B-A63D-1D4C3E785353Q38858593-F4ECFACB-4E3F-422F-AB50-1B2A653C4906Q38918064-96101CD6-9725-4664-80EB-42CEA055CD9EQ42181739-841FAD50-703B-49FF-A215-292137FDF795Q43257851-3F07E0AB-714F-4EFF-B819-49D009E4BDDBQ50852795-99E10570-37C6-491D-BC7E-AD7C3629D761Q52660505-BE147D68-5114-46DD-86A6-7203F0D2BC09Q53905101-3C52400B-A50F-4AE5-B71B-85FA7318DCD7Q59345617-E781988B-1A4C-412E-8271-27A281F92DE8Q60415861-CBB5D064-D9C3-44CB-AB5A-E58DB1CF4A9BQ64953662-66181835-F802-42A5-8F2F-CFBB64DE1F88Q90193958-AC8A4771-2827-423D-A222-B6C39532F4E1Q90222552-0AC50118-8085-4106-AD1A-47F2B0835104Q90930886-FE06E727-B684-4F92-8939-C9CCA0089A2EQ91640934-92207BA4-0259-4871-9EDB-1B85BC6B9629Q92209360-98303BB5-49F8-4A20-BFDF-43CEA2D6B15DQ92765338-5A12F0FE-5E49-43B7-BED8-31771B741141
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
C Cabral
@ast
C Cabral
@en
C Cabral
@es
C Cabral
@nl
type
label
C Cabral
@ast
C Cabral
@en
C Cabral
@es
C Cabral
@nl
prefLabel
C Cabral
@ast
C Cabral
@en
C Cabral
@es
C Cabral
@nl
P106
P1153
25222407900
P31
P496
0000-0003-4562-6683